Read more
Zusatztext Das vorliegende Buch über AT1-Antagonisten wendet sich an alle Ärzte inKlinik und Praxis! die sich mit der Therapie von Herz-Kreislauferkrankungen!insbesondere der essentiellen Hypertonie! der Herzinsuffizienz! dem Postmyokardinfarktund Nephropathien beschäftigen. Um dem Leser das Verständnis und den Umgangmit dieser neuen Substanzklasse zu erleichtern! sind den Kapiteln überHypertonie! Nephropathien und Herzerkrankungen ein Kapitel über die Physiologieund Pathophysiologie des Renin-Angiotensin-Systems sowie ein Kapitel überdie Pharmakologie und Klinische Pharmakologie der AT1-Antagonisten vorgeschaltet.Ein Kapitel über Neben- und Wechselwirkungen rundet das Werk ab. Informationen zum Autor KUMARIAH BALASUBRAMANIAM Pharmaceutical Adviser, Consumers International, MalaysiaMICHAEL BLAKENEY Herchel Smith Professor of Intellectual Property Law, Queen Mary Property Research Institute, LondonCARLOS M. CORREA Director, University of Buenos Aires Masters Programme on Science and Technology Policy and ManagementMARTIN KHOR Director of the Third World NetworkGARY LEA Centre for Commercial Law Studies, Queen Mary College, London UniversityJAMES LOVE Director, Ralph Nader's Consumer Project on Technology, USASTUART MACDONALD Professor of Information and Organization, Sheffield UniversityRUTH MAYNE Oxfam GB Policy AdviserSOL PICCIOTTO Professor of Law, Lancaster University Law SchoolWILLEM PRETORIUS BarristerSUMAN SAHAI Gene Campaign, IndiaALAN STORY Law School, University of KentJOHN SULSTON Founder of the Human Genome Project, Cambridge Klappentext Intellectual property rights such as patents can reduce access to knowledge in genetics, health, agriculture, education and information technology, particularly for people in developing countries. Global Intellectual Property Rights shows how the new global rules of intellectual property have been the product of the strategic behaviour of multinationals, rather than democratic dialogue. The final section of the book suggests strategies aimed at developing more flexible standard for poor countries, and for keeping knowledge in the intellectual commons. Zusammenfassung Intellectual property rights such as patents can reduce access to knowledge in genetics, health, agriculture, education and information technology, particularly for people in developing countries. Inhaltsverzeichnis Preface Notes on the Contributors List of Abbreviations Introduction; P.Drahos PART I: INNOVATION AND DIFFUSION OF TECHNOLOGY Exploring the Hidden Costs of Patents; S.Macdonald Pro-Competitive Measures under the TRIPS Agreement to Promote Technology Diffusion in Developing Countries; C.M.Correa PART II: DEVELOPMENT AND ACCESS TO TECHNOLOGY: GENETICS, HEALTH, AGRICULTURE, EDUCATION AND INFORMATION TECHNOLOGY Intellectual Property and the Human Genome; J.Sulston Access to Medicine and Compliance with the WTO TRIPS Accord: Models for State Practice in Developing Countries; J.Love Access to Medicines: Patents, Prices and Public Policy: Consumer Perspectives; K.Balasubramaniam Agricultural Research: Intellectual Property and the CGIAR System; M.Blakeney Don't Ignore Copyright, the 'Sleeping Giant' in the TRIPS and International Educational Agenda; A.Story Digital Millennium or Digital Domain? The Effect of IPRs in Software on Developing Countries; G.Lea PART III: KNOWLEDGE AND ACCESS: WHO MAKES THE RULES? Negotiating Intellectual Property Rights: Between Coercion and Dialogue; P.Drahos TRIPS and Developing Countries: How Level is the Playing Field?; W.Pretorius PART IV: OWNERSHIP OF KNOWLEDGE: CHANGING THE RULES Rethinking IPRS and the TRIPS Agreement; M.Khor India's Plant Variety Protection and Farmer's Rights Legislation; S.Sahai Defending the Public Interest in TRIPS and the WTO; S.Picciotto The Global NGO Campaign on Patents and Access to Medicines: An Oxfam Perspective; R.Mayne Index...
List of contents
Preface Notes on the Contributors List of Abbreviations Introduction; P.Drahos PART I: INNOVATION AND DIFFUSION OF TECHNOLOGY Exploring the Hidden Costs of Patents; S.Macdonald Pro-Competitive Measures under the TRIPS Agreement to Promote Technology Diffusion in Developing Countries; C.M.Correa PART II: DEVELOPMENT AND ACCESS TO TECHNOLOGY: GENETICS, HEALTH, AGRICULTURE, EDUCATION AND INFORMATION TECHNOLOGY Intellectual Property and the Human Genome; J.Sulston Access to Medicine and Compliance with the WTO TRIPS Accord: Models for State Practice in Developing Countries; J.Love Access to Medicines: Patents, Prices and Public Policy: Consumer Perspectives; K.Balasubramaniam Agricultural Research: Intellectual Property and the CGIAR System; M.Blakeney Don't Ignore Copyright, the 'Sleeping Giant' in the TRIPS and International Educational Agenda; A.Story Digital Millennium or Digital Domain? The Effect of IPRs in Software on Developing Countries; G.Lea PART III: KNOWLEDGE AND ACCESS: WHO MAKES THE RULES? Negotiating Intellectual Property Rights: Between Coercion and Dialogue; P.Drahos TRIPS and Developing Countries: How Level is the Playing Field?; W.Pretorius PART IV: OWNERSHIP OF KNOWLEDGE: CHANGING THE RULES Rethinking IPRS and the TRIPS Agreement; M.Khor India's Plant Variety Protection and Farmer's Rights Legislation; S.Sahai Defending the Public Interest in TRIPS and the WTO; S.Picciotto The Global NGO Campaign on Patents and Access to Medicines: An Oxfam Perspective; R.Mayne Index
